Transcriptional determination and functional specificity of myeloid cells: Making sense of diversity

Nature Reviews Immunology

Volumn 17, Issue 10, 2017, Pages 595-607

  Monticelli, Silvia ^a   Natoli, Gioacchino ^b,c  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b HUMANITAS UNIVERSITY   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CYTOKINE; DNA METHYLTRANSFERASE; GENOMIC DNA; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICRORNA; PATTERN RECOGNITION RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR PU 1;

BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL SPECIFICITY; CYTOKINE RELEASE; DENDRITIC CELL; DNA METHYLATION; DNA SEQUENCE; EXTRACELLULAR TRAP; GENE EXPRESSION REGULATION; GENOMICS; HISTONE MODIFICATION; HUMAN; INFLAMMATION; MACROPHAGE; MAST CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; ANIMAL; CYTOLOGY; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; INFECTION; INNATE IMMUNITY; METABOLISM;

ANIMALS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNITY, INNATE; INFECTION; MYELOID CELLS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 85030183085     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2017.51     Document Type: Review

References (132)

1. Ginhoux, F. & Guilliams, M. Tissue-resident macrophage ontogeny and homeostasis. Immunity 44, 439-449 (2016
2. Perdiguero, E. G. & Geissmann, F. The development and maintenance of resident macrophages. Nat. Immunol. 17, 2-8 (2016).
3. Varol, C. et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31, 502-512 (2009).
4. van de Laar, L. et al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages. Immunity 44, 755-768 (2016).
5. Bogunovic, M. et al. Origin of the lamina propria dendritic cell network. Immunity 31, 513-525 (2009).
6. Mantovani, A., Cassatella, M. A., Costantini, C. & Jaillon, S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519-531 (2011).
7. Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535 (2004). This study showed for the first time the release of extracellular chromatin traps by neutrophils.
8. Voehringer, D. Protective and pathological roles of mast cells and basophils. Nat. Rev. Immunol. 13, 362-375 (2013).
9. Rosenberg, H. F., Dyer, K. D. & Foster, P. S. Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 13, 9-22 (2013).
10. Galli, S. J., Borregaard, N. & Wynn, T. A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12, 1035-1044 (2011).
11. Kotzin, J. J. et al. The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan. Nature 537, 239-243 (2016).
12. Supajatura, V. et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109, 1351-1359 (2002).
13. Tamassia, N. et al. Molecular mechanisms underlying the synergistic induction of CXCL10 by LPS and IFN-gamma in human neutrophils. Eur. J. Immunol. 37, 2627-2634 (2007).
14. Ostuni, R., Natoli, G., Cassatella, M. A. & Tamassia, N. Epigenetic regulation of neutrophil development and function. Semin. Immunol. 28, 83-93 (2016).
15. Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
16. Natoli, G. Maintaining cell identity through global control of genomic organization. Immunity 33, 12-24 (2010).
17. Barozzi, I. et al. Coregulation of transcription factor binding and nucleosome occupancy through DNA features of mammalian enhancers. Mol. Cell 54, 844-857 (2014).
18. Glass, C. K. & Natoli, G. Molecular control of activation and priming in macrophages. Nat. Immunol. 17, 26-33 (2016).
19. Scott, E. W., Simon, M. C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577 (1994).
20. McKercher, S. R. et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658 (1996).
21. Walsh, J. C. et al. Cooperative and antagonistic interplay between PU.1 and GATA?2 in the specification of myeloid cell fates. Immunity 17, 665-676 (2002).
22. Rothenberg, E. V. et al. Transcriptional establishment of cell-type identity: dynamics and causal mechanisms of T?cell lineage commitment. Cold Spring Harb. Symp. Quant. Biol. 78, 31-41 (2013).
23. Giorgetti, L. et al. Noncooperative interactions between transcription factors and clustered DNA binding sites enable graded transcriptional responses to environmental inputs. Mol. Cell 37, 418-428 (2010).
24. Gregor, T., Tank, D. W., Wieschaus, E. F. & Bialek, W. Probing the limits to positional information. Cell 130, 153-164 (2007).
25. Kueh, H. Y., Champhekar, A., Nutt, S. L., Elowitz, M. B. & Rothenberg, E. V. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science 341, 670-673 (2013). In this study, the authors describe the post-transcriptional mechanisms that determine different concentrations of PU.1 in B lymphocytes and macrophages.
26. Dahl, R. et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat. Immunol. 4, 1029-1036 (2003).
27. Reddy, V. A. et al. Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood 100, 483-490 (2002).
28. Carotta, S. et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32, 628-641 (2010).
29. Tamura, T., Yanai, H., Savitsky, D. & Taniguchi, T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535-584 (2008).
30. Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T. & Ozato, K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13, 155-165 (2000).
31. Sasaki, H. et al. Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells. Blood 125, 358-369 (2015).
32. Mancino, A. et al. A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages. Genes Dev. 29, 394-408 (2015).
33. Kronlage, M. et al. Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci. Signal. 3, ra55 (2010).
34. Bours, M. J., Dagnelie, P. C., Giuliani, A. L., Wesselius, A. & Di Virgilio, F. P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front. Biosci. (Schol. Ed.) 3, 1443-1456 (2011).
35. Ulmann, L., Hirbec, H. & Rassendren, F. P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 29, 2290-2300 (2010).
36. Hambleton, S. et al. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365, 127-138 (2011).
37. Bornstein, C. et al. A negative feedback loop of transcription factors specifies alternative dendritic cell chromatin states. Mol. Cell 56, 749-762 (2014).
38. Becker, A. M. et al. IRF?8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood 119, 2003-2012 (2012).
39. Zhang, D. E. et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl Acad. Sci. USA 94, 569-574 (1997).
40. Nerlov, C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17, 318-324 (2007).
41. Avellino, R. et al. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation. Blood 127, 2991-3003 (2016).
42. Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163, 1663-1677 (2015). This study revisits the developmental trajectories in the myeloid lineage, combining single-cell RNA sequencing with index sorting.
43. Gorgoni, B., Maritano, D., Marthyn, P., Righi, M. & Poli, V. C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL?12 p40 and p35 mRNAs in macrophages. J. Immunol. 168, 4055-4062 (2002).
44. Screpanti, I. et al. Lymphoproliferative disorder and imbalanced T?helper response in C/EBP beta-deficient mice. EMBO J. 14, 1932-1941 (1995).
45. Tanaka, T. et al. Targeted disruption of the NF?IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361 (1995).
46. Yamanaka, R. et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc. Natl Acad. Sci. USA 94, 13187-13192 (1997).
47. Person, R. E. et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat. Genet. 34, 308-312 (2003).
48. Skokowa, J. et al. LEF?1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat. Med. 12, 1191-1197 (2006).
49. Shahlaee, A. H., Brandal, S., Lee, Y. N., Jie, C. & Takemoto, C. M. Distinct and shared transcriptomes are regulated by microphthalmia-associated transcription factor isoforms in mast cells. J. Immunol. 178, 378-388 (2007).
50. Qi, X. et al. Antagonistic regulation by the transcription factors C/EBPalpha and MITF specifies basophil and mast cell fates. Immunity 39, 97-110 (2013).
51. Arinobu, Y. et al. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc. Natl Acad. Sci. USA 102, 18105-18110 (2005).
52. Montagner, S. et al. TET2 regulates mast cell differentiation and proliferation through catalytic and non-catalytic activities. Cell Rep. 15, 1566-1579 (2016).
53. Iwasaki, H. et al. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev. 20, 3010-3021 (2006).
54. Tsai, F. Y. & Orkin, S. H. Transcription factor GATA?2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89, 3636-3643 (1997).
55. Dwyer, D. F., Barrett, N. A., Austen, K. F. & Immunological Genome Project Consortium. Expression profiling of constitutive mast cells reveals a unique identity within the immune system. Nat. Immunol. 17, 878-887 (2016).
56. Olsson, A. et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature 537, 698-702 (2016). In this study, the authors used single-cell RNA sequencing to characterize the mechanisms that control the differentiation of myeloid precursors into neutrophils or macrophages.
57. Drissen, R. et al. Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing. Nat. Immunol. 17, 666-676 (2016).
58. Curina, A. et al. High constitutive activity of a broad panel of housekeeping and tissue-specific cis-regulatory elements depends on a subset of ETS proteins. Genes Dev. 31, 399-412 (2017).
59. Zaret, K. S. & Carroll, J. S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227-2241 (2011).
60. Escoubet-Lozach, L. et al. Mechanisms establishing TLR4?responsive activation states of inflammatory response genes. PLoS Genet. 7, e1002401 (2011).
61. Mossadegh-Keller, N. et al. M?CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 497, 239-243 (2013).
62. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
63. Tong, A. J. et al. A stringent systems approach uncovers gene-specific mechanisms regulating inflammation. Cell 165, 165-179 (2016). In this work, the authors combined genomic and genetic approaches to dissect the specific regulatory requirements of individual inducible genes in the macrophage response to LPS.
64. Lamparter, D., Marbach, D., Rueedi, R., Bergmann, S. & Kutalik, Z. Genome-wide association between transcription factor expression and chromatin accessibility reveals regulators of chromatin accessibility. PLoS Comput. Biol. 13, e1005311 (2017).
65. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002).
66. Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484-492 (2012).
67. Baubec, T. et al. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature 520, 243-247 (2015).
68. Neri, F. et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature 543, 72-77 (2017).
69. Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 (Suppl.), 245-254 (2003).
70. Broske, A. M. et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat. Genet. 41, 1207-1215 (2009).
71. Challen, G. A. et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell 15, 350-364 (2014).
72. Leoni, C. et al. Dnmt3a restrains mast cell inflammatory responses. Proc. Natl Acad. Sci. USA 114, E1490-E1499 (2017). This study shows that DNA methylation-related processes are crucial to restrain mast cell acute and chronic inflammatory responses in vivo and in vitro.
73. Cronk, J. C. et al. Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli. Immunity 42, 679-691 (2015).
74. Leoni, C., Vincenzetti, L., Emming, S. & Monticelli, S. Epigenetics of T lymphocytes in health and disease. Swiss Med. Wkly 145, w14191 (2015).
75. Ito, S. et al. Tet proteins can convert 5?methylcytosine to 5?formylcytosine and 5?carboxylcytosine. Science 333, 1300-1303 (2011).
76. Tahiliani, M. et al. Conversion of 5?methylcytosine to 5?hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
77. Spruijt, C. G. et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152, 1146-1159 (2013).
78. Ko, M. et al. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl Acad. Sci. USA 108, 14566-14571 (2011).
79. Moran-Crusio, K. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20, 11-24 (2011).
80. Li, Z. et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118, 4509-4518 (2011).
81. Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25-38 (2011).
82. An, J. et al. Acute loss of TET function results in aggressive myeloid cancer in mice. Nat. Commun. 6, 10071 (2015).
83. Zhang, Q. et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL?6. Nature 525, 389-393 (2015).
84. Lio, C. W. et al. Tet2 and Tet3 cooperate with B?lineage transcription factors to regulate DNA modification and chromatin accessibility. eLife 5, e18290 (2016).
85. de la Rica, L. et al. PU.1 target genes undergo Tet2?coupled demethylation and DNMT3b?mediated methylation in monocyte-to?osteoclast differentiation. Genome Biol. 14, R99 (2013).
86. Krol, J., Loedige, I. & Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610 (2010).
87. Forster, A. et al. Dicer is indispensable for the development of murine mast cells. J. Allergy Clin. Immunol. 135, 1077-1080.e4 (2015).
88. Baer, C. et al. Suppression of microRNA activity amplifies IFN-gamma-induced macrophage activation and promotes anti-tumour immunity. Nat. Cell Biol. 18, 790-802 (2016).
89. Fukao, T. et al. An evolutionarily conserved mechanism for microRNA?223 expression revealed by microRNA gene profiling. Cell 129, 617-631 (2007).
90. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA?223. Nature 451, 1125-1129 (2008). Using mir?223?deleted mice, this study revealed a key role for miR?223 in the regulation of granulocyte differentiation and activation.
91. Wang, Q. et al. Down-regulation of microRNA?223 promotes degranulation via the PI3K/Akt pathway by targeting IGF?1R in mast cells. PLoS ONE 10, e0123575 (2015).
92. Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF?kappaB-dependent induction of microRNA miR?146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103, 12481-12486 (2006).
93. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. & Baltimore, D. MicroRNA?155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA 104, 1604-1609 (2007).
94. Bazzoni, F. et al. Induction and regulatory function of miR?9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl Acad. Sci. USA 106, 5282-5287 (2009).
95. Boldin, M. P. et al. miR?146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189-1201 (2011).
96. Rusca, N. et al. MiR?146a and NF?kappaB1 regulate mast cell survival and T lymphocyte differentiation. Mol. Cell. Biol. 32, 4432-4444 (2012).
97. Yang, L. et al. miR?146a controls the resolution of T cell responses in mice. J. Exp. Med. 209, 1655-1670 (2012).
98. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S. & Baltimore, D. Inositol phosphatase SHIP1 is a primary target of miR?155. Proc. Natl Acad. Sci. USA 106, 7113-7118 (2009).
99. Rodriguez, A. et al. Requirement of bic/microRNA?155 for normal immune function. Science 316, 608-611 (2007).
100. Ghisletti, S. et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32, 317-328 (2010). This study, together with reference 62, provided the first characterization and rational understanding of the macrophage repertoire of enhancers.
101. Sanjabi, S., Hoffmann, A., Liou, H. C., Baltimore, D. & Smale, S. T. Selective requirement for c?Rel during IL?12 P40 gene induction in macrophages. Proc. Natl Acad. Sci. USA 97, 12705-12710 (2000).
102. Sanjabi, S. et al. A c?Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation. Genes Dev. 19, 2138-2151 (2005).
103. Tamassia, N. et al. Cutting edge: an inactive chromatin configuration at the IL?10 locus in human neutrophils. J. Immunol. 190, 1921-1925 (2013).
104. Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36-49 (2014).
105. Borregaard, N. Neutrophils, from marrow to microbes. Immunity 33, 657-670 (2010).
106. Lekstrom-Himes, J. A., Dorman, S. E., Kopar, P., Holland, S. M. & Gallin, J. I. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon. J. Exp. Med. 189, 1847-1852 (1999).
107. Monticelli, S., Lee, D. U., Nardone, J., Bolton, D. L. & Rao, A. Chromatin-based regulation of cytokine transcription in Th2 cells and mast cells. Int. Immunol. 17, 1513-1524 (2005).
108. Min, B. et al. Basophils produce IL?4 and accumulate in tissues after infection with a Th2?inducing parasite. J. Exp. Med. 200, 507-517 (2004).
109. Motomura, Y. et al. Basophil-derived interleukin?4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity 40, 758-771 (2014).
110. Simon, D., Simon, H. U. & Yousefi, S. Extracellular DNA traps in allergic, infectious, and autoimmune diseases. Allergy 68, 409-416 (2013).
111. Mollerherm, H., von Kockritz-Blickwede, M. & Branitzki-Heinemann, K. Antimicrobial activity of mast cells: role and relevance of extracellular DNA traps. Front. Immunol. 7, 265 (2016).
112. von Kockritz-Blickwede, M. et al. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111, 3070-3080 (2008).
113. Yousefi, S. et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 14, 949-953 (2008).
114. Nagase, H. et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol. 171, 3977-3982 (2003).
115. Sabroe, I., Jones, E. C., Usher, L. R., Whyte, M. K. & Dower, S. K. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168, 4701-4710 (2002).
116. Matsushima, H., Yamada, N., Matsue, H. & Shimada, S. TLR3-, TLR7-, and TLR9?mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J. Immunol. 173, 531-541 (2004).
117. Choi, H. W. et al. Loss of bladder epithelium induced by cytolytic mast cell granules. Immunity 45, 1258-1269 (2016).
118. Piccolo, V. et al. Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk. Nat. Immunol. 18, 530-540 (2017).
119. Novakovic, B. et al. Glucan reverses the epigenetic state of LPS-induced immunological tolerance. Cell 167, 1354-1368.e14 (2016).
120. Rosenbauer, F. & Tenen, D. G. Transcription factors in myeloid development: balancing differentiation with transformation. Nat. Rev. Immunol. 7, 105-117 (2007).
121. Jubb, A. W., Young, R. S., Hume, D. A. & Bickmore, W. A. Enhancer turnover is associated with a divergent transcriptional response to glucocorticoid in mouse and human macrophages. J. Immunol. 196, 813-822 (2016).
122. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (2008).
123. Jaitin, D. A. et al. Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types. Science 343, 776-779 (2014).
124. Bhatt, D. M. et al. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 150, 279-290 (2012).
125. Core, L. J., Waterfall, J. J. & Lis, J. T. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322, 1845-1848 (2008).
126. Meyer, C. A. & Liu, X. S. Identifying and mitigating bias in next-generation sequencing methods for chromatin biology. Nat. Rev. Genet. 15, 709-721 (2014).
127. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213-1218 (2013).
128. Dekker, J., Marti-Renom, M. A. & Mirny, L. A. Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data. Nat. Rev. Genet. 14, 390-403 (2013).
129. Booth, M. J. et al. Oxidative bisulfite sequencing of 5?methylcytosine and 5?hydroxymethylcytosine. Nat. Protoc. 8, 1841-1851 (2013).
130. Dixit, A. et al. Perturb-Seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens. Cell 167, 1853-1866e.17 (2016).
131. Adamson, B. et al. A multiplexed single-cell CRISPR screening platform enables systematic dissection of the unfolded protein response. Cell 167, 1867-1882.e21 (2016).
132. Jaitin, D. A. et al. Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-Seq. Cell 167, 1883-1896.e15 (2016). References 130-132 combined CRISPR-Cas9?mediated screening with single-cell transcriptomics.